To generate the bulk mixtures from the single cell data, we split the data into training (18 patient samples) and test (8 patient samples) data sets, ensuring that all three breast cancer subtypes (ER+, HER2+ and TNBC) and major cell types were represented in both sets (Fig. 1b, Supplementary Data 1). This evidence concerns the gene ERBB2 and breast carcinoma.